0001104659-22-129514.txt : 20221222
0001104659-22-129514.hdr.sgml : 20221222
20221222160536
ACCESSION NUMBER: 0001104659-22-129514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221222
FILED AS OF DATE: 20221222
DATE AS OF CHANGE: 20221222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pisano Wayne
CENTRAL INDEX KEY: 0001743611
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32587
FILM NUMBER: 221482005
MAIL ADDRESS:
STREET 1: C/O PROVENTION BIO, INC.
STREET 2: P.O. BOX 666
CITY: OLDWICK
STATE: NJ
ZIP: 08858
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Altimmune, Inc.
CENTRAL INDEX KEY: 0001326190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202726770
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 910 CLOPPER ROAD
STREET 2: SUITE 201S
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 2406541450
MAIL ADDRESS:
STREET 1: 910 CLOPPER ROAD
STREET 2: SUITE 201S
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMATHENE, INC
DATE OF NAME CHANGE: 20071016
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP
DATE OF NAME CHANGE: 20050505
4
1
tm2233389-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-12-22
0
0001326190
Altimmune, Inc.
ALT
0001743611
Pisano Wayne
C/O ALTIMMUNE, INC., 910 CLOPPER ROAD
SUITE 201S
GAITHERSBURG
MD
20878
1
0
0
0
Common Stock, par value $0.0001
2022-12-22
4
M
0
20000
2.60
A
28498
D
Common Stock, par value $0.0001
2022-12-22
4
S
0
20000
15.0134
D
8498
D
Stock Options (option to buy)
2.60
2022-12-22
4
M
0
20000
0.00
D
2029-01-02
Common Stock, par value $0.0001
20000
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.0000 to $15.0900, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The option became vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date.
/s/ Richard Eisenstadt, as Attorney-in-Fact
2022-12-22